domingo, 20 de setembro de 2026
PesquisarExplore
Via News Knowledge File

U.S. Food and Drug Administration

government agency80% conf.·synced Sep 20, 2026

U.S. federal agency responsible for regulating drugs and medical devices

59
sourced metrics
3196
relationships
20
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Parameter Count
6months_priority_review
Jun 15, 2026source
Ai Devices Cleared
1350devices
Feb 3, 2026source
Drug Approvals
17drugs
Jan 20, 2026⚠ sources conflictsource
Approval Decisions
32decisions
Jan 20, 2026source
Ai Device Authorizations
250devices
Sep 1, 2025source
Total Ai Devices Authorized
1247count
Jun 30, 2025source
Cardiology Ai Algorithms Total
116algorithms
May 1, 2025source
Ai Algorithms Cleared May 2025
39algorithms
May 1, 2025source
Accelerated Approvals
11drugs
Jan 1, 2025source
Approved Car T Products
7products
Jan 1, 2025source
Approved Gene Therapies Global
36products
Jan 1, 2025source
Approved Non Modified Cell Therapies
71products
Jan 1, 2025source
Biologics Approved
12biologics
Jan 1, 2025source
Fast Track Designations
18drugs
Jan 1, 2025source
First In Class Drugs
20drugs
Jan 1, 2025source
New Molecular Entities Approved
34NMEs
Jan 1, 2025source
Novel Drugs Approved
46drugs
Jan 1, 2025source
Oncology Approvals
50treatments
Jan 1, 2025source

Stated objectives

Evaluate appropriate regulatory pathway for CBD products beyond existing food and dietary supplement frameworks

source
stated

Reduce lead in fruit-based baby foods

source
target: 10 ppb by 2025-01-01 00:00:00stated

Reduce lead in root vegetables and dry infant cereals

source
target: 20 ppb by 2025-01-01 00:00:00stated

Complete regulatory review of TransCon CNP with PDUFA target action date

source
by 2026-02-28 00:00:00stated

FDA supports AI-based medical devices and healthcare digitization programs to accelerate AI integration in U.S. healthcare

source
stated

FDA aims to accelerate regenerative medicine advancement through expedited approval pathways while maintaining rigorous safety and efficacy standards

source
stated

Speed up the development of safe, effective, and innovative medical devices critical to public health through the TPLC Advisory Program Pilot

source
stated

Review CagriSema regulatory application for weight management

source
by 2026-01-01 00:00:00stated

Expedite development and review timelines of drugs that demonstrate potential to treat serious conditions through Fast Track designation program

source
stated

Set daily sodium intake target for food categories including salad dressings

source
target: 2750 mg daily, 220 mg per serving for salad dressings by 2025-01-01 00:00:00stated

Relationship graph · 3196 connections

regulates
2691
regulated by
310
approved by
65
located in
34
governs
21
subsidiary of
13
regulated
12
approved
9
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
Sinalizamos conflitos abertamente ›
Verificado recentemente
Verificado com a fonte original
4,982
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,982 factos verificados com a fonte5,299 documentos-fonte arquivados
Consulte estes dados → isubstrate.com